DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gibson CM, Chi G, Halaby R. , et al; APEX Investigators.
Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
Circulation 2017;
135 (07) 648-655
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.